Assignee
CERO THERAPEUTICS INC
US·2 granted patents·9 pending applications·8 citations·filing 2017–2024
Top patents by PatentIndex Score
11 records- 0189US11655282B2Chimeric engulfment receptor moleculesCERO THERAPEUTICS INC·Filed 2021·Granted May 23, 2023·5 cites·12 claims
- 0283US11708423B2Chimeric engulfment receptor molecules and methods of useCERO THERAPEUTICS INC·Filed 2018·Granted Jul 25, 2023·3 cites·27 claims
- 0372US2024368244A1Chimeric engulfment receptor moleculesCERO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0466US2024174766A1Chimeric engulfment receptor molecules and methods of useCERO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0563US2024285684A1Anti-cd72 chimeric receptors and uses thereofCERO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0658US2024285682A1Chimeric tim receptors and uses thereofCERO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0751US2020055917A1Chimeric engulfment receptor moleculesCERO THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 0847US2021253696A1Bivalent chimeric engulfment receptors and uses thereofCERO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0946US2024058446A1Chimeric tim4 receptors and uses thereofCERO THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1045US2021024607A1Expression vectors for chimeric engulfment receptors, genetically modified host cells, and uses thereofCERO THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1145US2021015865A1Chimeric engulfment receptors and uses thereof for neurodegenerative diseasesCERO THERAPEUTICS INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CERO THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →